GUFICBIONSEGufic Biosciences Limited· PharmaceuticalsMediumNeutral
Announced Thu, 24 Apr · 15:49 IST

Jayesh Choksi (For and on behalf of Promoter Group/ PACs of the Company) has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Creeping Acquisition Near ThresholdOwnership Changes View source PDF

GUFICBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Jayesh Choksi, representing the Promoter Group and Persons Acting in Concert (PACs) of Gufic Biosciences, has submitted a disclosure under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation specifically governs the disclosure of incremental shareholding changes by promoters who have already crossed open-offer thresholds, in the context of creeping acquisition norms. The public announcement does not specify the exact quantum or direction of the shareholding change, and investors would need to refer to the detailed filing for specifics.

Likely market impact

Likely a routine compliance filing with limited immediate impact on stock price, though investors should review the detailed disclosure to understand any change in promoter group shareholding that may affect control or trigger further disclosures.